在患有口腔状细胞癌的患者中,PCLO与瘤突变负担和免疫有关

相关实验视频

Updated: Sep 8, 2025

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

Yuping Liu¹, Ye Zhang², Lijing Zhu¹

¹Department of Oral Pathology, Peking University School and Hospital of Stomatology, Beijing 100081, China.

Current issues in molecular biology

|July 23, 2025

概括

瘤突变负担 (TMB) 和PCLO基因突变对口腔状细胞癌 (OSCC) 的影响预后. PCLO突变与更高的TMB和更差的存活率有关,这表明PCLO是OSCC的预测生物标志物.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
生物标志物发现发现

背景情况:

口腔状细胞癌 (OSCC) 是一个重要的全球健康问题.
确定可靠的预后生物标志物对于改善OSCC患者的治疗结果至关重要.
瘤突变负担 (TMB) 和特定基因突变越来越多地被认为具有预后影响.

研究的目的:

通过分析TMB和基因突变之间的关联来确定OSCC预后的预测生物标志物.
验证PCLO基因作为OSCC预后的潜在预测生物标志物.

主要方法:

利用了来自癌症基因组图谱 (TCGA) 和国际癌症基因组联盟 (ICGC) 数据库的基因突变数据.
进行免疫细胞透分析,卡普兰-梅尔和考克斯回归分析,以评估生存关联.
采用基因组丰富分析 (GSEA) 和免疫组织化学来探索通路关联和蛋白质表达.

主要成果:

在TCGA和ICGC数据集之间确定了17个共享突变基因.
与野生类型相比,PCLO突变的OSCC患者的TMB显著更高.
PCLO突变与较低的整体存活率 (OS) 有关,并被确定为显著的预后因素.
GSEA和免疫细胞分析表明PCLO与免疫系统的关联.
在具有PCLO突变的OSCC组织中,PCLO表达升高.

结论:

PCLO突变是OSCC的显著预后因素.
PCLO突变可能会影响OSCC的免疫反应.
PCLO突变显示出作为OSCC患者预后预测生物标志物的前景.

关键词:

这就是PCLO PCLO PCLO.免疫细胞的透.口腔状细胞癌的癌症.小小的小小的小小的小小的小小的瘤突变负担瘤突变负担

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Loss of Tumor Suppressor Gene Functions

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...